MedPath

Onderzoek naar de werkzaamheid van Caphosol tegen mucositis bij kinderen met kanker.

Completed
Conditions
Hospitalised children with cancer therapy induced mucositis
Registration Number
NL-OMON24436
Lead Sponsor
niversitair Centrum van Groningen, Utrecht, VU en Leiden
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

1. Age 4-18 years;

2. Cancer therapy induced oral mucositis;

Exclusion Criteria

1. Impossibility to rinse the mouth;

2. Previous study participation;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Days of mucositis > grade I.
Secondary Outcome Measures
NameTimeMethod
1. Days of analgesic use;<br /><br>2. Total dose of analgesics;<br /><br>3. Peak level of mucositis;<br /><br>4. Peak level of pain;<br /><br>5. Number of days with pain (VAS score > 0);<br /><br>6. Number of positive blood cultures;<br /><br>7. Number of days with tube feeding;<br /><br>8. Number of days total parental feeding;<br /><br>9. Tolerability of the product.
© Copyright 2025. All Rights Reserved by MedPath